LAX Airport Shows Support For Breast Cancer Awareness
OCTOBER 13 IS METASTATIC BREAST CANCER AWARENESS DAY
LAX Lights Up the Dark Side of Breast Cancer
Los Angeles. October 13 is Metastatic Breast Cancer Awareness Day. Over 160,000 Americans are living with metastatic breast cancer (also known as Stage IV or advanced breast cancer). Metastatic breast cancer accounts for 100% of breast cancer deaths, and at the time of diagnosis these patients have a median life expectancy of only two years. METAvivor is a national non-profit organization that gives voice to these patients and funds Stage IV-specific breast cancer research.
From football fields to markets and malls, we are awash with pink in honor of Breast Cancer Awareness Month. But runs, races and pink ribbon products only tell part of the story. Breast cancer messaging focuses on awareness: get your mammogram because “early detection saves lives.” Yet women and men diagnosed with breast cancer at any stage can become metastatic.
Metastatic breast cancer means that cancer has traveled beyond the breast and taken hold in distant places such as the lung, liver, bones or brain. There is no “cure” for these patients, and they aren’t held as shining examples of breast cancer success. They account for all of the roughly 40,000 breast cancer deaths each year.
Thanks to the efforts of METAvivor supporter Ruth Segal, the colorful pylons at LAX will be lit October 21 – 25, with METAvivor’s colors: green for renewal and hope, teal for healing and spirituality, and pink representing breast cancer. Ruth enlisted the help of LA City Council Member Tom LaBonge. “I am grateful to the City of LA and LAX for standing up to support this critical cause,” says Ruth. “It is time to break through the ‘pink awareness’ and educate people about the vital urgency of focusing research on the treatment and cure for metastatic breast cancer, the breast cancer that kills.”
METAvivor is an all-volunteer effort where 100% of donations and fundraiser proceeded are used to fund metastatic breast cancer research grants.